<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04272476</url>
  </required_header>
  <id_info>
    <org_study_id>ChengduUTCM</org_study_id>
    <nct_id>NCT04272476</nct_id>
  </id_info>
  <brief_title>The Activation on Prefrontal Cortex With Acupuncture and Moxibustion for Major Depressive Disorder: A Study of Functional Near Infrared Spectroscopy</brief_title>
  <acronym>ACUfNIRS</acronym>
  <official_title>The Activation on Prefrontal Cortex With Acupuncture and Moxibustion for Major Depressive Disorder: A Study of Functional Near Infrared Spectroscopy (ACUfNIRS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chengdu University of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chengdu University of Traditional Chinese Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the activation on prefrontal cortex with acupuncture and moxibustion for
      major depressive disorder.Half of participants will receive the treatment of acupuncture and
      moxibustion, while the other participants will receive the fluoxetine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Major depressive disorder (MDD) is a psychiatric condition with high morbidity, disability,
      suicide and recurrence rate and become the hot and difficult topics in the medical study.
      Given the unsatisfactory response rates of many FDA-approved antidepressants, acupuncture is
      increasingly considered an important alternative therapy. A large number of clinical trials
      have confirmed that acupuncture is a generally safe, effective, and well-tolerated therapy
      for depression, but for MDD, the acupuncture clinical trials were only reported out of China.
      According to the clinical symptoms in patients with MDD, the chief TCM patterns are liver qi
      constraint and heart yang insufficiency, and the secondary TCM patterns are blood stasis, qi
      and blood deficiency. So we propose to combine acupuncture with moxibustion and select Baihui
      (DU20), shenting(DU24), Neiguan (PC6), Hegu (LI4), Taichong (LV3), Zusanli(ST36), Zhongwan
      (RN 12) and Gaunyuan (RN4) to Soothe the Liver, regulating the heart, warm the yang qi, boost
      qi and invigorate blood for MDD. We hypothesize that the acupuncture's antidepressant effect
      is based on the neural network reconstructing mechanism through studying the cerebral cortex
      function, hippocampal synaptic plasticity, Neurons electrophysiological change. We will
      employ multi-disciplinary methods in neuropsychology, neuroimaging, computer science, and
      electrophysiology to explore the important mechanism underlying acupuncture and moxibustion
      treating MDD.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2014</start_date>
  <completion_date type="Actual">December 2019</completion_date>
  <primary_completion_date type="Actual">December 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Hamilton score as a measure of depressive degree</measure>
    <time_frame>1, 2, 4, 6, 8 weeks after treatment</time_frame>
    <description>Evaluating the patient's depressive degree</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The fNIRS score as a measure of prefrontal oxyhemoglobin</measure>
    <time_frame>1, 2, 4, 6, 8 weeks after treatment</time_frame>
    <description>Evaluating the patient's prefrontal oxyhemoglobin</description>
  </primary_outcome>
  <other_outcome>
    <measure>The pHQ-9 score</measure>
    <time_frame>Screening criteria</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Depressive Disorder, Major</condition>
  <arm_group>
    <arm_group_label>Acupuncture and moxibustion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Acupuncture points: Baihui(GV 20), Mingmen(GV 4), Bilateral Neiguan(PC 6), Bilateral Shenmen(HT 7), Bilateral Hegu(LI 4), Bilateral Zusanli(ST 36), Bilateral Taichong(LR 3). Each treatment takes about thirty minutes,3 times a week(treatment on Monday, Wednesday and Friday) for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Western medicine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fluoxetine 20 mg capsule by mouth every day for 8 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>acupuncture and moxibustion</intervention_name>
    <arm_group_label>Acupuncture and moxibustion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluoxetine</intervention_name>
    <arm_group_label>Western medicine</arm_group_label>
    <other_name>Prozac</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnostic criteria of CCMD-3 and DSM-4 depression;

          -  the score of PHQ-9 should be equal to or more than 15 points; the score of Hamilton
             Depression Rating Scale should be more than 18 points;

          -  without any drug treatment over the past 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wu Junmei, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chengdu University of Traditional Chinese Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Teaching Hospital of Chengdu University of Traditional Chinese Medicine</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>March 31, 2015</study_first_submitted>
  <study_first_submitted_qc>February 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 17, 2020</study_first_posted>
  <last_update_submitted>February 13, 2020</last_update_submitted>
  <last_update_submitted_qc>February 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chengdu University of Traditional Chinese Medicine</investigator_affiliation>
    <investigator_full_name>Li ying</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Acupuncture</keyword>
  <keyword>Moxibustion</keyword>
  <keyword>Major Depressive Disorder</keyword>
  <keyword>MDD</keyword>
  <keyword>Neural Network Reconstruction</keyword>
  <keyword>cerebral function</keyword>
  <keyword>functional near infrared spectroscopy (fNIRS) imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluoxetine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

